5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.72▲ | 1.71▲ | 1.68▲ | 1.65▲ | 1.42▲ |
MA10 | 1.69▲ | 1.66▲ | 1.65▲ | 1.53▲ | 1.28▲ |
MA20 | 1.66▲ | 1.65▲ | 1.66▲ | 1.41▲ | 1.15▲ |
MA50 | 1.66▲ | 1.62▲ | 1.54▲ | 1.25▲ | N/A |
MA100 | 1.64▲ | 1.51▲ | 1.43▲ | 1.13▲ | N/A |
MA200 | 1.52▲ | 1.38▲ | 1.30▲ | 1.08▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.013▲ | 0.010▲ | 0.002▲ | 0.030▲ | 0.066▲ |
RSI | 70.519▲ | 67.210▲ | 66.475▲ | 76.419▲ | 74.684▲ |
STOCH | 98.889▲ | 97.222▲ | 64.815 | 86.243▲ | 83.194▲ |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -8.046▲ | -4.490▲ |
CCI | 127.992▲ | 185.276▲ | 229.345▲ | 121.043▲ | 217.954▲ |
BBANDS | $IRD Bollinger Bands Expanding | Set Alert |
Friday, September 12, 2025 05:10 AM
Opus Genetics (IRD) announced that the Compensation Committee of its Board of Directors approved equity awards under the Company’s 2021 Inducement ...
|
Thursday, September 04, 2025 01:00 AM
RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases ...
|
Wednesday, September 03, 2025 05:00 PM
RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
25/09/25 | 1.64 | 1.7585 | 1.56 | 1.72 | 405,395 |
24/09/25 | 1.65 | 1.7086 | 1.60 | 1.64 | 224,355 |
23/09/25 | 1.74 | 1.74 | 1.63 | 1.66 | 311,122 |
22/09/25 | 1.56 | 1.72 | 1.52 | 1.71 | 714,689 |
19/09/25 | 1.50 | 1.59 | 1.4207 | 1.52 | 870,017 |
18/09/25 | 1.42 | 1.49 | 1.41 | 1.49 | 376,744 |
17/09/25 | 1.40 | 1.435 | 1.38 | 1.43 | 213,518 |
16/09/25 | 1.37 | 1.42 | 1.35 | 1.40 | 215,069 |
15/09/25 | 1.36 | 1.4393 | 1.35 | 1.37 | 148,826 |
12/09/25 | 1.47 | 1.47 | 1.35 | 1.38 | 325,727 |
|
|
||||
|
|
||||
|
|